AIDS-ASSOCIATED KAPOSIS-SARCOMA (KS) CELLS EXPRESS ONCOSTATIN-M (OM)-SPECIFIC RECEPTOR BUT NOT LEUKEMIA INHIBITORY FACTOR/OM RECEPTOR OR INTERLEUKIN-6 RECEPTOR - COMPLETE BLOCK OF OM-INDUCED KS CELL-GROWTH AND OM BINDING BY ANTI-GP130 ANTIBODIES

被引:48
作者
MURAKAMIMORI, K
TAGA, T
KISHIMOTO, T
NAKAMURA, S
机构
[1] HUNTINGTON MEM HOSP,INST MOLEC MED & TECHNOL,PASADENA,CA 91105
[2] UNIV SO CALIF,DEPT MED,DIV HEMATOL,LOS ANGELES,CA 90033
[3] OSAKA UNIV,DEPT MED 3,OSAKA 565,JAPAN
[4] OSAKA UNIV,INST MOLEC & CELLULAR BIOL,OSAKA 565,JAPAN
关键词
CYTOKINE RECEPTOR; GROWTH FACTOR; BIOLOGICAL SIGNALING; BINDING SITES; GROWTH INHIBITION;
D O I
10.1172/JCI118167
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Oncostatin M (OM), which shares functional similarity and structural homology to leukemia inhibitory factor (LIF) and interleukin-6 (IL-6), functions as a potent growth factor for AIDS-associated Kaposi's sarcoma-derived cells (AIDS-KS cells), OM was also suggested to bind to the LIF receptor (LIF/OM receptor), which consists of a signal transducing subunit for LIF and IL-6 (gp130) and a LIF receptor alpha-subunit. Recent studies indicate that IL-6 has growth-stimulating activity for AIDS-KS cells, However, we find that AIDS-KS cell growth is exclusively induced by OM and not by LIF or IL-6, We also observed the lack of binding properties of AIDS-KS cells for LIF and IL-6, Scatchard plots revealed the existence of two affinity classes of OM receptor sites on AIDS-KS cells, with K-d values of 6-12 pM (high affinity) and 521-815 pM (low affinity), In competition binding studies, we find that the OM-specific receptor, but not the LIF/OM receptor, contributes to the OM-specific growth stimulation of AIDS-KS cells, We also noted that anti-gp130 antibodies can completely abolish OM-induced growth stimulation of AIDS-KS cells as well as OM binding to AIDS-KS cells, PCR amplification clearly revealed high levels of gp130 expression in AIDS-KS cells, while the transcript of LIF receptor alpha-subunit or IL-6 receptor alpha-subunit was not observed, Therefore, we conclude that (a) AIDS-KS cells express the OM-specific receptor with high and low affinity, but not the LIF/OM receptor; (b) gp130 on AIDS-KS cells plays a key role in OM binding and signaling on the OM-specific receptor; and (c) the lack of biological response of AIDS-KS cells to IL-6 and LIF can be explained by the absence of the IL-6 and LIF/OM receptors. All this evidence shows the correlation of OM-specific biological activity with expression of the OM-specific receptor and the involvement of gp130 on this receptor, as based on findings in in vitro growth assays and binding experiments for AIDS-KS cells.
引用
收藏
页码:1319 / 1327
页数:9
相关论文
共 37 条
[1]   ONCOSTATIN-M STIMULATES TYROSINE PROTEIN-PHOSPHORYLATION IN PARALLEL WITH THE ACTIVATION OF P42(MAPK)/ERK-2 IN KAPOSI CELLS - EVIDENCE THAT THIS PATHWAY IS IMPORTANT IN KAPOSI CELL-GROWTH [J].
AMARAL, MC ;
MILES, S ;
KUMAR, G ;
NEL, AE .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02) :848-857
[2]   NEUROPOIETIC CYTOKINES IN THE HEMATOPOIETIC FOLD [J].
BAZAN, JF .
NEURON, 1991, 7 (02) :197-208
[3]  
BROWN TJ, 1991, J IMMUNOL, V147, P2175
[4]  
BROWN TJ, 1987, J IMMUNOL, V139, P2977
[5]   AIDS-KAPOSIS SARCOMA-DERIVED CELLS EXPRESS CYTOKINES WITH AUTOCRINE AND PARACRINE GROWTH EFFECTS [J].
ENSOLI, B ;
NAKAMURA, S ;
SALAHUDDIN, SZ ;
BIBERFELD, P ;
LARSSON, L ;
BEAVER, B ;
WONGSTAAL, F ;
GALLO, RC .
SCIENCE, 1989, 243 (4888) :223-226
[6]   THE IL-6 SIGNAL TRANSDUCER, GP130 - AN ONCOSTATIN-M RECEPTOR AND AFFINITY CONVERTER FOR THE LIF RECEPTOR [J].
GEARING, DP ;
COMEAU, MR ;
FRIEND, DJ ;
GIMPEL, SD ;
THUT, CJ ;
MCGOURTY, J ;
BRASHER, KK ;
KING, JA ;
GILLIS, S ;
MOSLEY, B ;
ZIEGLER, SF ;
COSMAN, D .
SCIENCE, 1992, 255 (5050) :1434-1437
[7]  
GREEN LL, 1994, NAT GENET, V7, P13, DOI 10.1038/ng0594-13
[8]  
GROVE RI, 1991, J BIOL CHEM, V266, P18194
[9]   ONCOSTATIN-M IS A MITOGEN FOR RABBIT VASCULAR SMOOTH-MUSCLE CELLS [J].
GROVE, RI ;
EBERHARDT, C ;
ABID, S ;
MAZZUCCO, C ;
LIU, JW ;
KIENER, P ;
TODARO, G ;
SHOYAB, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :823-827
[10]  
HAVERKOS HW, 1985, NEW ENGL J MED, V312, P1518